Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
6,892.00
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
6,892.00
6,136.00
5,624.00
4,557.00
3,779.00
3,069.00
Expenditure (Ex Depriciation)
Stock Adjustments
-34.00
6.00
-190.00
-221.00
-159.00
-105.00
Raw Materials Consumed
5,119.00
4,634.00
4,582.00
3,778.00
3,141.00
2,530.00
Power & Fuel Cost
55.00
52.00
45.00
31.00
17.00
13.00
Employee Cost
884.00
726.00
625.00
545.00
393.00
338.00
Operating Expenses
156.00
124.00
82.00
65.00
44.00
28.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
43.00
51.00
35.00
30.00
19.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
6.00
7.00
6.00
5.00
4.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
6,285.00
5,648.00
5,270.00
4,291.00
3,506.00
2,852.00
Operating Profit (PBDIT) excl Other Income
607.00
487.00
354.00
265.00
272.00
216.00
Other Income
71.00
48.00
40.00
46.00
31.00
21.00
Operating Profit (PBDIT)
678.00
535.00
394.00
311.00
303.00
238.00
Interest
120.00
102.00
96.00
83.00
66.00
54.00
Profit before Depriciation and Tax
558.00
433.00
297.00
228.00
237.00
183.00
Depreciation
282.00
249.00
224.00
181.00
119.00
88.00
Profit Before Taxation & Exceptional Items
275.00
183.00
73.00
47.00
117.00
95.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
275.00
183.00
73.00
47.00
117.00
95.00
Provision for Tax
55.00
33.00
7.00
-2.00
23.00
31.00
Profit After Tax
219.00
150.00
65.00
50.00
94.00
63.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
429.00
279.00
213.00
163.00
66.00
1.00
Profit Available for appropriations
649.00
429.00
279.00
213.00
161.00
65.00
Appropriations
649.00
429.00
279.00
213.00
161.00
65.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
18.33
12.57
5.48
4.17
8.55
6.13
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.33% vs 9.09% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 24.69% vs 37.57% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 17.46% vs 6.38% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 46.18% vs 129.09% in Mar 2025
Compare Profit and Loss Results of Medplus Health
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
6,892.00
7,829.00
-937.00
-11.97%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
6,892.00
7,829.00
-937.00
-11.97%
Expenditure (Ex Depriciation)
Stock Adjustments
-34.00
140.00
-174.00
-124.29%
Raw Materials Consumed
5,119.00
3,131.00
1,988.00
63.49%
Power & Fuel Cost
55.00
88.00
-33.00
-37.50%
Employee Cost
884.00
918.00
-34.00
-3.70%
Operating Expenses
156.00
681.00
-525.00
-77.09%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
35.00
472.00
-437.00
-92.58%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
61.00
-55.00
-90.16%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
6,285.00
6,606.00
-321.00
-4.86%
Operating Profit (PBDIT) excl Other Income
607.00
1,223.00
-616.00
-50.37%
Other Income
71.00
77.00
-6.00
-7.79%
Operating Profit (PBDIT)
678.00
1,300.00
-622.00
-47.85%
Interest
120.00
413.00
-293.00
-70.94%
Profit before Depriciation and Tax
558.00
887.00
-329.00
-37.09%
Depreciation
282.00
705.00
-423.00
-60.00%
Profit Before Taxation & Exceptional Items
275.00
181.00
94.00
51.93%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
275.00
83.00
192.00
231.33%
Provision for Tax
55.00
23.00
32.00
139.13%
Profit After Tax
219.00
59.00
160.00
271.19%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
429.00
0.00
429.00
0%
Profit Available for appropriations
649.00
59.00
590.00
1,000.00%
Appropriations
649.00
59.00
590.00
1,000.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
18.33
0.49
17.84
3,640.82%
Profit And Loss - Net Sales
Net Sales 6,892.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.33% vs 9.09% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 607.37 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 24.69% vs 37.57% in Mar 2025
Profit And Loss - Interest
Interest 120.49 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.46% vs 6.38% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 219.61 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 46.18% vs 129.09% in Mar 2025






